13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000064803
Total reported value
$225.2M
$225.2M
33 檔
56.9%
The Q1 2026 SEC filing reveals that CVS HEALTH Corp held a total portfolio value of $225.2M, covering 33 public equity positions.
In Q1 2026, CVS HEALTH Corp displayed an active expansion posture, initiating 26 new positions and adding to 2 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including SPY, IEI, SHY) accounted for 56.9% of total reported equity market value during Q1 2026.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 26.83% | -26.83% | EXIT | |
| 2 | IEI | Ishares 3-7 Year Treasury Bo | ETF-Gov Bonds | 10.21% | -0.67% | — | |
| 3 | SHY | Ishares 1-3 Year Treasury Bo | ETF-Gov Bonds | 9.07% | +0.34% | — | |
| 4 | IGSB | Ishares 1-5y Inv Grade CORP | ETF-Other | 7.29% | +13.43% | +211.86% | |
| 5 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 7.00% | -0.42% | — | |
| 6 | USHY | Ishares Broad Usd High Yield | ETF-High Yield | 6.04% | +1.82% | +29.84% | |
| 7 | EMB | Ishares Jp Morgan Usd Emergi | ETF-Other | 4.74% | +2.97% | — | |
| 8 | VCSH | Vanguard S/t CORP Bond ETF | ETF-Corp Bonds | 4.48% | -0.27% | — | |
| 9 | VGIT | Vanguard Intermediate-term T | ETF-Other | 2.38% | -0.15% | — | |
| 10 | JPST | Jpmorgan Ultra-short Income | ETF-Other | 2.35% | -0.14% | — | |
| 11 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 2.34% | -0.12% | — | |
| 12 | VCIT | Vanguard Int-term Corporate | ETF-Corp Bonds | 2.34% | -0.14% | — | |
| 13 | IGLB | Ishares 10+ Year Inv Gr CORP | ETF-Other | 2.34% | +1.55% | — | |
| 14 | IGIB | Ishares 5-10y Inv Grade CORP | ETF-Corp Bonds | 2.33% | +8.06% | — | |
| 15 | RSP | Invesco S&p 500 Equal Weight | ETF-Large Cap & Growth | 2.08% | -1.89% | — | |
| 16 | IEF | Ishares 7-10 Year Treasury B | ETF-Gov Bonds | 1.57% | -0.10% | — | |
| 17 | XLV | Ss Health Care Select Sector | ETF-Other | 0.83% | -0.83% | EXIT | |
| 18 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 0.82% | +1.10% | — | |
| 19 | VEA | Vanguard Ftse Developed ETF | ETF-Other | 0.60% | -0.60% | EXIT | |
| 20 | XLU | St Sr Utl Sl Se Spdr Etf-usd | ETF-Other | 0.54% | -0.54% | EXIT | |
| 21 | IEMG | Ishares Core Msci Emerging | ETF-Emerging Markets | 0.49% | -0.49% | EXIT | |
| 22 | XLI | Ss Industrial Select Sector | ETF-Other | 0.46% | -0.46% | EXIT | |
| 23 | VGLT | Vanguard Long-term Treasury | ETF-Gov Bonds | 0.42% | -0.42% | EXIT | |
| 24 | UUP | Invesco Db US Dollar Index B | ETF-Large Cap & Growth | 0.39% | -0.39% | EXIT | |
| 25 | PFIX | Simplify Interest Rate Hedge | ETF-Other | 0.32% | -0.32% | EXIT | |
| 26 | BNO | United States Brent Oil Fund | ETF-Other | 0.25% | -0.24% | EXIT | |
| 27 | MOO | Vaneck Agribusiness ETF | ETF-Other | 0.24% | -0.24% | EXIT | |
| 28 | XLB | Ss Materials Select Sector | ETF-Other | 0.24% | -0.24% | EXIT | |
| 29 | CORN | Teucrium Corn Fund | ETF-Other | 0.23% | -0.23% | EXIT | |
| 30 | XLP | Ss Consumer Staples Sel Sect | ETF-Other | 0.23% | -0.23% | EXIT | |
| 31 | WEAT | Teucrium Wheat Fund | ETF-Other | 0.22% | -0.22% | EXIT | |
| 32 | XLE | Ss Energy Select Sector | ETF-Other | 0.20% | -0.20% | EXIT | |
| 33 | PRU | Prudential Financial Inc | Stock-Financials | 0.12% | +0.01% | — |
According to official SEC Form 13F filings, CVS HEALTH Corp reported a total U.S. public equity portfolio value of $225.2M across 33 disclosed positions in Q1 2026.
During Q1 2026, CVS HEALTH Corp's top holdings by market value included SPY (26.8%)、IEI (10.2%)、SHY (9.1%). The largest single position, SPY, represented 26.8% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
IEI
市值: $21.7M
Top Position Liquidated / Trimmed
HCAT
前期市值: $77.1K
In Q1 2026, CVS HEALTH Corp made 31 total portfolio adjustments, initiating 26 new buys, adding to 2 positions, trimming 1 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.